|
25 Apr 2025
|
Audited Results |
- |
|
28 Jan 2025
|
Quarterly Results |
- |
|
23 Oct 2024
|
Quarterly Results |
- |
|
26 Jul 2024
|
Quarterly Results |
- |
|
01 May 2024
|
Audited Results |
- |
|
29 Jan 2024
|
Quarterly Results |
- |
|
30 Oct 2023
|
Quarterly Results |
- |
|
01 Aug 2023
|
Quarterly Results |
- |
|
28 Apr 2023
|
Audited Results |
- |
|
27 Jan 2023
|
Quarterly Results |
- |
|
28 Oct 2022
|
Quarterly Results |
- |
|
22 Jul 2022
|
Quarterly Results |
- |
|
29 Apr 2022
|
Audited Results |
- |
|
28 Jan 2022
|
Quarterly Results |
- |
|
22 Oct 2021
|
Quarterly Results |
- |
|
24 Jul 2021
|
Quarterly Results |
- |
|
01 May 2021
|
Audited Results |
- |
|
23 Jan 2021
|
Quarterly Results |
- |
|
31 Oct 2020
|
Quarterly Results |
- |
|
25 Jul 2020
|
Quarterly Results |
- |
|
23 May 2020
|
Audited Results |
- |
|
01 Feb 2020
|
Quarterly Results |
- |
|
02 Nov 2019
|
Quarterly Results |
- |
|
03 Aug 2019
|
Quarterly Results |
- |
|
18 May 2019
|
Audited Results |
- |
|
04 Feb 2019
|
Quarterly Results |
- |
|
03 Nov 2018
|
Quarterly Results |
- |
|
06 Aug 2018
|
Quarterly Results |
- |
|
19 May 2018
|
Audited Results |
- |
|
03 Feb 2018
|
Quarterly Results |
- |
|
13 Nov 2017
|
Quarterly Results |
- |
|
10 Aug 2017
|
Quarterly Results |
- |
|
20 May 2017
|
Audited Results |
- |
|
13 Feb 2017
|
Quarterly Results |
- |
|
09 Nov 2016
|
Quarterly Results & Right Issue |
- |
|
06 Aug 2016
|
Quarterly Results |
- |
|
21 May 2016
|
Audited Results & Others |
To the Right Issue and to decide all other matters relating to the Right Issue. |
|
09 Mar 2016
|
Appointment of Compliance Officer |
Appointed, Mr. Abdul Gafoor as Compliance Officer of the Company effective from March 11, 2016. |
|
27 Jan 2016
|
Quarterly Results |
Appointed Mr. Chintan Jitendra Shah as Independent Director of the Company, subject to the approval of the Shareholders in a general meeting. |
|
06 Nov 2015
|
Quarterly Results |
- |
|
25 Aug 2015
|
Others |
Appointed Mr. Azadar Hussain Khan as Additional director of the Company. |
|
10 Aug 2015
|
Quarterly Results |
- |
|
26 May 2015
|
Audited Results |
- |
|
02 Feb 2015
|
Quarterly Results |
- |
|
08 Nov 2014
|
Quarterly Results |
- |
|
13 Aug 2014
|
Quarterly Results |
- |
|
26 May 2014
|
Audited Results |
- |
|
14 Feb 2014
|
Quarterly Results |
- |
|
06 Nov 2013
|
Quarterly Results |
- |
|
12 Aug 2013
|
Quarterly Results |
- |
|
08 Feb 2013
|
Quarterly Results |
- |
|
14 Nov 2012
|
Audited & Quarterly Results |
for the year ended March 31, 2012 |
|
14 Feb 2011
|
Quarterly Results |
- |
|
11 Dec 2010
|
Consolidated Audited Results |
To consider the followings: 1. Audited consolidated financial results for the year ended March 31,2010. 2. conducting of 21st Annual General Meeting of the Company. (Revised) |
|
26 Oct 2010
|
Quarterly Results |
- |
|
05 Aug 2010
|
Audited & Quarterly Results |
- |
|
26 Feb 2010
|
Appointment of Director's |
The Board has appointed A. Gopal Rao, Mr. A. Raghu Vasu, Mr. M. R. Vikram & Dr. K. Uma Devi as Directors of the Company. |
|
13 Jan 2010
|
Quarterly Results |
- |
|
16 Nov 2009
|
Audited, Qtr. Results & ESOP |
The Company allotted 4250 Shares under Zenotech ESOS, 2005 but this resolution will be implemented only with the leave of Hon'ble Company Law Board, in view of orders passed by them. (Revised) |
|
01 Oct 2009
|
Others |
To accept the resignation of Mr. S M Bhutani and Lt. Col. (Retd.) Sukhdev Singh Gill from the Directionship of the Company & to induct Mr. M R Vikram & Dr. K Uma Devi to Board of the Company. |
|
26 Aug 2009
|
Audited & Quarterly Results |
To approve the notice calling 19th AGM, Directors Report includes Report on Management Discussion and Analysis forming part of Directors report and Corporate Governance Report. (Revised) |
|
06 Mar 2009
|
Quarterly Results |
- |
|
17 Oct 2008
|
Quarterly Results |
- |
|
30 Jul 2008
|
Quarterly Results |
- |
|
30 Jun 2008
|
Audited Results & Allotment of shares |
To consider allotment of 25,000 equity shares of the Company of Rs 10/- each, at an exercisable price of Rs 69.70 per share against the 25,000 options, which were granted under Zenotech ESOS, 2005. |
|
31 Jan 2008
|
Quarterly Results |
- |
|
31 Oct 2007
|
Quarterly Results |
- |
|
03 Oct 2007
|
Preferential Issue of shares |
- |
|
29 Aug 2007
|
Quarterly Results |
- |
|
21 Jun 2007
|
Audited Results |
- |
|
28 Feb 2007
|
Quarterly Results |
- |
|
31 Oct 2006
|
Quarterly Results |
- |
|
25 Aug 2006
|
Others |
The allotment of 20,00,000 equity shares of Rs 10/- each per share, issued on a preferential basis at a price (including premium) of Rs 100/- each, to M/s. Ranbaxy Laboratories Ltd. |
|
31 Jul 2006
|
Quarterly Results |
- |
|
29 Apr 2006
|
Quarterly Results |
- |
|
28 Jan 2006
|
Quarterly Results |
(Revised) |
|
29 Nov 2005
|
Half Yearly Results |
- |
|
30 Sep 2005
|
Amalgamation |
- |
|
31 Aug 2005
|
Quarterly Results & Amalgamation |
Amalgamation of Credence Pharmaceuticals Ltd, Hemarus Healthcare Pvt Ltd & Zenotech Inc. USA with the Company. |
|
23 May 2005
|
To consider conversion of warrants |
To consider conversion of warrants issued on a preferential basis and consequent allotment of equity shares upon exercising of conversion option by the allottee Dr. Jayaram Chigurupati. |
|
09 Apr 2005
|
Qtr Results & Conversion of warrants |
To Consider conversion of 2,00,000 warrants & consequent allotment of equivalent number of equity shares upon exercising of conversion option by the allottee, Dr. Jayaram Chigurupati. |
|
26 Jan 2005
|
Quarterly Results |
Reissue of 1,82,900 forfeited equity shares at Rs.131.60/-each per share to Tripuraneni Investments Inc. |
|
19 Aug 2004
|
Others |
To consider allotment of equity share warrants on preferential basis to Dr. Jay Chigurupati, Managing Director of the company of 7,50,000 share warrants. |
|
12 Jun 2004
|
Preferential Issue of shares |
Re-issue of forfeited equity shares to Andhra Pradesh state Finance Corporation. |
|
31 Jan 2004
|
Quarterly Results |
- |
|
23 Dec 2003
|
Others |
Re-issue of forfeited eq shares and issue of eq shares/warrants on preferential basis. |
|
10 Nov 2003
|
Others |
To consider inter alia a proposal for merger/acquisitionof Biotech/Pharma company. |
|
31 Jul 2001
|
Quarterly Results |
- |
|
24 Apr 2000
|
Quarterly Results |
- |
|
31 Jan 2000
|
Quarterly Results |
- |